Tag: Sotrovimab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Sotrovimab

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results

Added to Collection on: 2022-05-06 02:25:57

Tags for this article:

Medical specialties
Health
Life Sciences
COVID-19 drug development
Monoclonal antibodies
Antiviral drugs
Occupational safety and health
Sotrovimab
SARS-CoV-2 Omicron variant
COVID-19 pandemic
GlaxoSmithKline
COVID-19
Vir Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
Vir Biotech, Wuxi Biologics End COVID-19 Antibody Collaboration | BioSpace

Added to Collection on: 2022-05-24 02:36:27

Tags for this article:

Medical specialties
Medicine
COVID-19 drug development
Monoclonal antibodies
Clinical medicine
Antiviral drugs
Sotrovimab
Bamlanivimab
Coronavirus spike protein
SARS-CoV-2 Omicron variant
WuXi Biologics
COVID-19
Vir Biotechnology

Click the tags to see associated articles and topics

View Article Details
New £800-a-dose Covid drug that protects vulnerable patients | Daily Mail Online

Added to Collection on: 2022-06-19 05:33:07

Tags for this article:

Clinical trials
Drugs
Health
Vaccines
COVID-19 vaccination in the United States
RNA vaccines
Adenoviridae
Vaccine controversies
SARS-CoV-2 Omicron variant
COVID-19 vaccine
Sotrovimab
Vaccination
United Kingdom
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Patients treated with monoclonal antibodies during Covid delta surge had low rates of ...

Added to Collection on: 2022-06-27 14:40:24

Tags for this article:

Medical specialties
COVID-19 drug development
Monoclonal antibodies
Medicine
Drugs
Bamlanivimab
Casirivimab/imdevimab
Sotrovimab
SARS-CoV-2 Delta variant
SARS-CoV-2 Omicron variant
Variants of SARS-CoV-2
COVID-19
Raymund Razonable

Click the tags to see associated articles and topics

View Article Details
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by ... - Nature

Added to Collection on: 2022-07-02 14:32:48

Tags for this article:

Medical specialties
COVID-19 pandemic in South Africa
Coronaviruses
Sarbecovirus
Clinical medicine
COVID-19 pandemic in Botswana
SARS-CoV-2 Omicron variant
Zoonoses
Variants of SARS-CoV-2
Sotrovimab
Severe acute respiratory syndrome coronavirus 2
SARS-CoV-2 Beta variant

Click the tags to see associated articles and topics

View Article Details
BA.2.75: A Dark Horse In The Covid Pandemic - Forbes

Added to Collection on: 2022-07-11 19:03:21

Tags for this article:

COVID-19 pandemic in Botswana
COVID-19 pandemic in South Africa
SARS-CoV-2 Omicron variant
Infectious diseases
Health
Contemporary history
TMPRSS2
Ba
Sotrovimab
SARS-CoV-2 Delta variant
COVID-19 pandemic
United States
India
LinkedIn

Click the tags to see associated articles and topics

View Article Details
Aerie Pharmaceuticals (NASDAQ:AERI) & Vir Biotechnology (NASDAQ:VIR) Head to Head Contrast

Added to Collection on: 2022-07-18 12:19:43

Tags for this article:

Life Sciences
Biotechnology
Aerie Pharmaceuticals
Industry economics)
Gilead Sciences
Aerie
Samsung Biologics
Sotrovimab
Vir Biotechnology Inc.
S&P 500 INDEX - CBOE
Aerie Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers ...

Added to Collection on: 2022-07-25 09:20:27

Tags for this article:

Medical specialties
Branches of biology
Medicine
COVID-19 pandemic in South Africa
Zoonoses
Sarbecovirus
COVID-19 pandemic in India
COVID-19 pandemic in Botswana
SARS-CoV-2 Omicron variant
Sotrovimab
Variants of SARS-CoV-2
Coronavirus spike protein

Click the tags to see associated articles and topics

View Article Details
Hennion & Walsh Asset Management Inc. Has $325,000 Stock Holdings in Vir ...

Added to Collection on: 2024-01-16 19:02:05

Tags for this article:

Stock market
Equity securities
Penny stock
Stock
Investment
Sotrovimab
Dow Jones Industrial Average
Vir Biotechnology Inc.

Click the tags to see associated articles and topics

View Article Details
COVID drugs more often given to Medicare patients who least need them, study suggests

Added to Collection on: 2024-01-26 21:57:52

Tags for this article:

COVID-19 drug development
Treatment and management of COVID-19
Nirmatrelvir/ritonavir
Bamlanivimab
Casirivimab/imdevimab
Sotrovimab
Molnupiravir
Remdesivir
Nirmatrelvir
COVID-19
COVID-19 drug repurposing research
Coronavirus spike protein

Click the tags to see associated articles and topics

View Article Details